این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Journal of Basic Medical Sciences، جلد ۱۹، شماره ۳، صفحات ۳۰۰-۳۰۹
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Co-treatment by docetaxel and vinblastine breaks down P-glycoprotein mediated chemo-resistance
چکیده انگلیسی مقاله Objective(s): Chemoresistance remains the main causes of treatment failure and mortality in cancer patients. There is an urgent need to investigate novel approaches to improve current therapeutic modalities and increase cancer patients' survival. Induction of drug efflux due to overexpression of P-glycoproteins is considered as an important leading cause of multidrug resistance. In this study, we investigated the role of combination treatments of docetaxel and vinblastine in overcoming P-glycoprotein mediated inhibition of apoptosis and induction of cell proliferation in human non-small cell lung carcinoma cells. Materials and Methods:Cell proliferation and apoptosis were assessed using MTT assay and DAPI staining, respectively. P-glycoprotein expression was evaluated in gene and protein levels by Real-time RT-PCR and Western blot analysis, respectively. Results: Combination treatment of the cells with docetaxel and vinblastine decreased the IC50 values for docetaxel from (30±3.1) to (15±2.6) nM and for vinblastine from (30±5.9) to (5±5.6) nM (P≤0.05). P-glycoprotein mRNA expression level showed a significant up-regulation in the cells incubated with each drug alone (P≤0.001). Incubation of the cells with combined concentrations of both agents neutralized P-glycoprotein overexpression (P≤0.05). Adding verapamil, a P-glycoprotein inhibitor caused a further increase in the percentage of apoptotic cells when the cells were treated with both agents. Conclusion:Our results suggest that combination therapy along with P-glycoprotein inhibition can be considered as a novel approach to improve the efficacy of chemotherapeutics in cancer patients with high P-glycoprotein expression.
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله مهسا محسنی | mahsa mohseni
research center for pharmaceutical nanotechnology, tabriz university of medical sciences, tabriz, iran|department of medical biotechnology, faculty of advanced medical sciences, tabriz university of medical sciences, tabriz, iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تبریز (Tabriz university of medical sciences)

ناصر صمدی | nasser samadi
research center for pharmaceutical nanotechnology, tabriz university of medical sciences, tabriz, iran|department of medical biotechnology, faculty of advanced medical sciences, tabriz university of medical sciences, tabriz, iran|department of biochemistry and clinical laboratories, faculty of medicine, tabriz university of medical sciences, tabriz, iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تبریز (Tabriz university of medical sciences)

پریسا قنبری | parisa ghanbari
research center for pharmaceutical nanotechnology, tabriz university of medical sciences, tabriz, iran|department of medical biotechnology, faculty of advanced medical sciences, tabriz university of medical sciences, tabriz, iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تبریز (Tabriz university of medical sciences)

بهمن یوسفی | bahman yousefi
department of biochemistry and clinical laboratories, faculty of medicine, tabriz university of medical sciences, tabriz, iran|proteomics laboratory, department of clinical biochemistry, faculty of medicine, tabriz university of medical sciences, tabriz, iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تبریز (Tabriz university of medical sciences)

مریم طبسی نژاد | maryam tabasinezhad
research center for pharmaceutical nanotechnology, tabriz university of medical sciences, tabriz, iran|department of medical biotechnology, faculty of advanced medical sciences, tabriz university of medical sciences, tabriz, iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تبریز (Tabriz university of medical sciences)

سیمین شریفی | simin sharifi
department of medical biotechnology, faculty of advanced medical sciences, tabriz university of medical sciences, tabriz, iran|faculty of pharmacy, tabriz university of medical sciences, tabriz, iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تبریز (Tabriz university of medical sciences)

حسین ناظمیه | hossein nazemiyeh
department of medical biotechnology, faculty of advanced medical sciences, tabriz university of medical sciences, tabriz, iran|faculty of pharmacy, tabriz university of medical sciences, tabriz, iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تبریز (Tabriz university of medical sciences)

نشانی اینترنتی http://ijbms.mums.ac.ir/article_6649.html
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده Original Article
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات